Importance of the Molecular Epidemiological Monitoring of Carbapenem-Resistant Pseudomonas aeruginosa

키워드

참고문헌 (8)

1. Rice LB, "Federal funding for the study of antimicrobial resistance in nosocomial pathogens : no ESKAPE", J Infect Dis, 197, pp.1079~1081 (2008)
2. Kim YJ, "Challenges of carbapenem-resistant Pseudomonas aeruginosa in infection control and antibiotic management", Ann Lab Med, 44, pp.1~2 (2024)
3. Jeong S, "Changing genotypic distribution, antimicrobial susceptibilities, and risk factors of urinary tract infection caused by carbapenemase-producing Pseudomonas aeruginosa", Ann Lab Med, 44, pp.38~46 (2024)
4. Tacconelli E, "Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis", Lancet Infect Dis, 18, pp.318~327 (2018)
5. Yoon EJ, "Mobile carbapenemase genes in Pseudomonas aeruginosa", Front Microbiol, 12, pp.614058~ (2021)
6. Kim N, "Clonal distribution and its association with the carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa isolates from Korean hospitals", Ann Lab Med, 44, pp.410~417 (2024)
7. Yoo JS, "Dissemination of genetically related IMP-6-producing multidrug-resistant Pseudomonas aeruginosa ST235 in South Korea", Int J Antimicrob Agents, 39, pp.300~304 (2012)
8. Choi YJ, "Emergence of NDM-1-producing Pseudomonas aeruginosa sequence type 773 clone : shift of carbapenemase molecular epidemiology and spread of 16S rRNA methylase genes in Korea", Ann Lab Med, 43, pp.196~199 (2023)

관련 논문AI추천